Skip to main content
. 2018 May 28;171(2):435–442. doi: 10.1007/s10549-018-4824-9

Table 1.

Baseline characteristics of female beneficiaries by BRCA testing and time period (1997–2016) in the MarketScan database

Characteristics All Ever BRCA tested Non BRCA tested
1997–2016 1997–2002 2003–2012 2013–2016 1997–2016 1997–2002 2003–2012 2013–2016 1997–2016 1997–2002 2003–2012 2013–2016
Total N 46,364,847 (100.0) 3,045,858 (100.0) 34,127,783 (100.0) 9,191,206 (100.0) 121,480 (100.0) 3,709 (100.0) 79,618 (100.0) 38,153 (100.0) 46,243,367 (100.0) 3,042,149 (100.0) 34,048,165 (100.0) 9,153,053 (100.0)
Age Mean (SD) 43.5 (15.9) 47.4 (17.3) 43.6 (15.8) 42.1 (15.5) 42.0 (10.8) 38.4 (8.5) 41.8 (10.4) 42.7 (11.6) 43.5 (15.9) 47.4 (17.3) 43.6 (15.8) 42.0 (15.5)
Median (IQR) 43.0 (31.0–54.0) 46.0 (34.0–59.0) 43.0 (31.0–54.0) 41.0 (29.0–53.0) 42.0 (34.0–50.0) 39.0 (32.0–45.0) 42.0 (34.0–50.0) 42.0 (34.0–52.0) 43.0 (31.0–54.0) 46.0 (34.0–59.0) 43.0 (31.0–54.0) 41.0 (29.0–53.0)
Age group 18–34 15,220,699 (32.8) 775,173 (25.5) 11,011,382 (32.3) 3,434,144 (37.4) 32,714 (26.9) 1,225 (33.0) 21,108 (26.5) 10,381 (27.2) 15,187,985 (32.8) 773,948 (25.4) 10,990,274 (32.3) 3,423,763 (37.4)
35–49 14,845,205 (32.0) 963,974 (31.6) 11,151,037 (32.7) 2,730,194 (29.7) 56,934 (46.9) 2,127 (57.3) 38,527 (48.4) 16,280 (42.7) 14,788,271 (32.0) 961,847 (31.6) 11,112,510 (32.6) 2,713,914 (29.7)
50–64 12,272,751 (26.5) 795,550 (26.1) 9,073,954 (26.6) 2,403,247 (26.1) 30,590 (25.2) 352 (9.5) 19,496 (24.5) 10,742 (28.2) 12,242,161 (26.5) 795,198 (26.1) 9,054,458 (26.6) 2,392,505 (26.1)
65–74 2,068,107 (4.5) 256,433 (8.4) 1,448,898 (4.2) 362,776 (3.9) 1,097 (0.9) 5 (0.1) 428 (0.5) 664 (1.7) 2,067,010 (4.5) 256,428 (8.4) 1,448,470 (4.3) 362,112 (4.0)
75+ 1,958,085 (4.2) 254,728 (8.4) 1,442,512 (4.2) 260,845 (2.8) 145 (0.1) 0 (0.0) 59 (0.1) 86 (0.2) 1,957,940 (4.2) 254,728 (8.4) 1,442,453 (4.2) 260,759 (2.8)
Insurance Commercial 42,280,609 (91.2) 2,533,752 (83.2) 31,192,651 (91.4) 8,554,206 (93.1) 120,141 (98.9) 3,701 (99.8) 79,085 (99.3) 37,355 (97.9) 42,160,468 (91.2) 2,530,051 (83.2) 31,113,566 (91.4) 8,516,851 (93.0)
Medicare 4,073,647 (8.8) 509,520 (16.7) 2,928,646 (8.6) 635,481 (6.9) 1,319 (1.1) 6 (0.2) 522 (0.7) 791 (2.1) 4,072,328 (8.8) 509,514 (16.7) 2,928,124 (8.6) 634,690 (6.9)
Missing 10,591 (0.0) 2,586 (0.1) 6,486 (0.0) 1,519 (0.0) 20 (0.0) 2 (0.1) 11 (0.0) 7 (0.0) 10,571 (0.0) 2,584 (0.1) 6,475 (0.0) 1,512 (0.0)
Geographic regions Midwest 10,439,354 (22.5) 934,730 (30.7) 7,846,230 (23.0) 1,658,394 (18.0) 21,136 (17.4) 852 (23.0) 14,991 (18.8) 5,293 (13.9) 10,418,218 (22.5) 933,878 (30.7) 7,831,239 (23.0) 1,653,101 (18.1)
Northeast 7,764,864 (16.7) 397,152 (13.0) 5,468,414 (16.0) 1,899,298 (20.7) 30,288 (24.9) 454 (12.2) 19,066 (23.9) 10,768 (28.2) 7,734,576 (16.7) 396,698 (13.0) 5,449,348 (16.0) 1,888,530 (20.6)
South 18,041,956 (38.9) 1,195,917 (39.3) 13,347,681 (39.1) 3,498,358 (38.1) 46,321 (38.1) 1,951 (52.6) 29,889 (37.5) 14,481 (38.0) 17,995,635 (38.9) 1,193,966 (39.2) 13,317,792 (39.1) 3,483,877 (38.1)
West 9,071,156 (19.6) 442,880 (14.5) 6,670,023 (19.5) 1,958,253 (21.3) 21,673 (17.8) 446 (12.0) 14,035 (17.6) 7,192 (18.9) 9,049,483 (19.6) 442,434 (14.5) 6,655,988 (19.5) 1,951,061 (21.3)
Missing 1,047,517 (2.3) 75,179 (2.5) 795,435 (2.3) 176,903 (1.9) 2,062 (1.7) 6 (0.2) 1,637 (2.1) 419 (1.1) 1,045,455 (2.3) 75,173 (2.5) 793,798 (2.3) 176,484 (1.9)
Follow Up months Mean (sd) 33.6 (34.9) 73.3 (65.8) 34.5 (31.9) 16.7 (11.7) 52.3 (44.2) 186.0 (41.1) 60.9 (38.3) 21.3 (12.2) 33.5 (34.9) 73.2 (65.7) 34.5 (31.8) 16.7 (11.7)
Median (IQR) 24.3 (12.1–43.6) 48.7 (18.2–121.6) 24.3 (12.1–48.7) 12.1 (8.1–24.3) 36.5 (21.2–73.0) 182.6 (161.3–220.1) 57.8 (31.4–82.1) 21.3 (11.1–33.4) 24.2 (12.1–43.6) 48.7 (18.2–120.7) 24.3 (12.1–48.7) 12.1 (8.1–24.3)

SD standard deviation, IQR interquartile range